Par Equity LLP - Andrew Castell
Par Equity is an Edinburgh-based venture capital boutique active across the United Kingdom. It invests in innovative small companies with high growth potential within a number of carefully selected sub-sectors, including software, medical devices, energy-efficient lighting and technical textiles. Although portfolio companies do include businesses serving consumer markets, Par Equity is particularly interested in business-to-business propositions. Investors include many individuals with directly relevant experience of the sub-sectors Par Equity invests in, providing a reserve of intellectual capital to be deployed alongside financial capital. Par Equity offers execution-only investment services to business angels as well as managing an evergreen EIS fund (the Par Syndicate EIS Fund) that invests alongside and on the same terms as business angels in SEIS and EIS-qualifying companies.
Parkwalk Advisors - Enrico D'Angelo
Parkwalk Advisors is one of the UK’s leading technology Enterprise Investment Scheme fund managers. Parkwalk invests in high growth, knowledge intensive companies seeking to develop and commercialise technology and innovation originating from UK universities, research intensive institutions and technology clusters.
Founded in 2009, Parkwalk has assets under management of over £160m and has backed over 85 companies. Parkwalk is now part of IP Group plc, a FTSE 250 company with a market capitalisation of £1.7bn and the UK’s leading developer of intellectual property-based businesses. IP Group has agreements with over 80% of the UK Russell Group Universities, including Oxford, Cambridge and Imperial.
The Parkwalk Opportunities EIS Fund is a growth-targeted investment fund providing investors access to a portfolio of knowledge intensive technology companies, an area the Government continues to support. Investors will get exposure to a range of investments from AIM listed to seed stage companies.
Parkwalk also manages a series of early-stage funds in conjunction with the technology transfer offices of the Universities of Cambridge, Oxford and Bristol.
Prosper Capital - Paul Thompson
We help individual businesses and funds to raise money from investors while complying with their regulatory obligations. These businesses can then access alternative sources of funding such as crowdfunding and networks of sophisticated investors. We have helped to raise over £200 million for small businesses over the last 5 year and have extensive experience of EIS and SEIS. We have particular expertise in property crowdfunding, technology, green energy and media.
We can act as alternative investment fund manager (AIFM) for your fund; provide your business with regulatory permissions on a monthly basis through our authorised representative service or help your business apply to the FCA to become directly regulated. We have retail permissions and can operate unregulated collective investment schemes (UCIS).
Prosper Capital is authorised and regulated by the Financial Conduct Authority (FCA). A full list of the activities that the firm is authorised to carry out can be found on the Financial Services Register on the FCA’s website at https://register.fca.org.uk
Deepbridge Capital LLP - Ian Warwick
Deepbridge is a different kind of investment manager. We work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. We also partner with innovative and committed management teams to help UK based companies realise their potential and become successful leading-edge businesses. Deepbridge operates across four principle divisions: disruptive technology, sustainable technologies, life sciences and renewable energy.
EMV Capital Ltd - Dr. Ilian Iliev
EMV Capital is an award-winning VC investor specialising in early stage high-growth deep tech companies in the life science, sustainability and industrials sectors in the UK and internationally.
EMV Capital develops unique investment strategies for each portfolio company, drawing on its EIS fund and extensive network of private investors, family offices, institutions, and corporate VCs. Delivery and successful execution of these investment strategies enables innovative portfolio companies to raise funding to drive transformational growth.
EMV Capital is a wholly owned subsidiary of NetScientific plc (AIM:NSCI), a life sciences and technology commercialisation and investment group.
EMV Capital has a multi-disciplinary team of specialist investors, portfolio managers, capital raisers, legal, finance, marketing and support staff. The company is focused on primary and secondary investments, through debt and/or equity.